Cargando…
New Topoisomerase I mutations are associated with resistance to camptothecin
BACKGROUND: Topoisomerase I (TOP1) is a nuclear enzyme that catalyzes the relaxation of supercoiled DNA during DNA replication and transcription. TOP1 is the molecular target of camptothecin and related drugs such as irinotecan and SN38 (irinotecan's active metabolite). Irinotecan is widely use...
Autores principales: | Gongora, Céline, Vezzio-Vie, Nadia, Tuduri, Sandie, Denis, Vincent, Causse, Annick, Auzanneau, Céline, Collod-Beroud, Gwenaëlle, Coquelle, Arnaud, Pasero, Philippe, Pourquier, Philippe, Martineau, Pierre, Del Rio, Maguy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120799/ https://www.ncbi.nlm.nih.gov/pubmed/21619602 http://dx.doi.org/10.1186/1476-4598-10-64 |
Ejemplares similares
-
Multiplexed-Based Assessment of DNA Damage Response to Chemotherapies Using Cell Imaging Cytometry
por: Vezzio-Vié, Nadia, et al.
Publicado: (2022) -
Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases
por: Del Rio, Maguy, et al.
Publicado: (2013) -
Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype
por: Cherradi, Sara, et al.
Publicado: (2019) -
Protein domains provide a new layer of information for classifying human variations in rare diseases
por: Corcuff, Mélanie, et al.
Publicado: (2023) -
FL118, a novel camptothecin derivative, is insensitive to ABCG2 expression and shows improved efficacy in comparison with irinotecan in colon and lung cancer models with ABCG2-induced resistance
por: Westover, David, et al.
Publicado: (2015)